AGENUS INC — Director's Dealing 2017

Jan 30, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (agen)
CIK: 0001098972
Period of Report: 2017-01-26

Reporting Person: Cuillerot Jean-Marie (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-26	Stock Option, Right to Buy	$3.72	A	100000	Acquired	2027-01-26	Common Stock (100000)	Direct

Footnotes

F1: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests in three equal annual installments beginning on the one-year anniversary of the grant date.